[
  {
    "ts": null,
    "headline": "Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors",
    "summary": "In the closing of the recent trading day, Abbott (ABT) stood at $118.77, denoting a -0.15% change from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=7c413b0b882d870ce50ba2da93672629000a5f91240fd411a7e64f4013d0bb05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732920606,
      "headline": "Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors",
      "id": 131715233,
      "image": "https://media.zenfs.com/en/zacks.com/bdc2850a48a0f40806db817a9e24f36f",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Abbott (ABT) stood at $118.77, denoting a -0.15% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=7c413b0b882d870ce50ba2da93672629000a5f91240fd411a7e64f4013d0bb05"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=64e066a42868faf45d773f62ad0e47ef1769f906bf94af5a5e4f477e36d77dae",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732898160,
      "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "id": 131776179,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=64e066a42868faf45d773f62ad0e47ef1769f906bf94af5a5e4f477e36d77dae"
    }
  },
  {
    "ts": null,
    "headline": "Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues",
    "summary": "Abbott has a unique opportunity to scale a capital-efficient licensing model that can help the emerging market population access life-changing medicines.",
    "url": "https://finnhub.io/api/news?id=9173f1bc2d1864e9f33ea33e4ffbbeadb78a5174cc420efc08140a864d71b00f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732893300,
      "headline": "Growing EPD Business Supports ABT Stock Amid Macroeconomic Issues",
      "id": 131710058,
      "image": "https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott has a unique opportunity to scale a capital-efficient licensing model that can help the emerging market population access life-changing medicines.",
      "url": "https://finnhub.io/api/news?id=9173f1bc2d1864e9f33ea33e4ffbbeadb78a5174cc420efc08140a864d71b00f"
    }
  },
  {
    "ts": null,
    "headline": "Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)",
    "summary": "Key Insights The projected fair value for Abbott Laboratories is US$137 based on 2 Stage Free Cash Flow to Equity...",
    "url": "https://finnhub.io/api/news?id=dffdbaefb5b8f3219e28b8b610f3f4d3c87e586a5b04faba710f1da680b788d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732888810,
      "headline": "Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)",
      "id": 131708357,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights The projected fair value for Abbott Laboratories is US$137 based on 2 Stage Free Cash Flow to Equity...",
      "url": "https://finnhub.io/api/news?id=dffdbaefb5b8f3219e28b8b610f3f4d3c87e586a5b04faba710f1da680b788d4"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems",
    "summary": "Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems are included in this Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=c90fb651673e3bf8f9e6b8b98dddaf7e134aa06593c63011eb3fe1d78afe8ae1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732863600,
      "headline": "The Zacks Analyst Blog Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems",
      "id": 131702879,
      "image": "https://media.zenfs.com/en/zacks.com/edb25d10e45af60c5d4a41341d213d75",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott, BlackRock, ConocoPhillips, NetSol and Optex Systems are included in this Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=c90fb651673e3bf8f9e6b8b98dddaf7e134aa06593c63011eb3fe1d78afe8ae1"
    }
  }
]